e-Article

Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL

Document Type

Article

Author

Mikhailova, E.; Popov, A.; Roumiantseva, J.; Budanov, O.; Lagoyko, S.; Zharikova, L.; Miakova, N.; Litvinov, D.; Khachatryan, L.; Pshonkin, A.; Novichkova, G.; Karachunskiy, A.; Ponomareva, N.; Boichenko, E.; Varfolomeeva, S.; Dinikina, J.; Henze, G.

Source

In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 6 June 2024, 12(6))

Subject

Language

English

ISSN

20511426

Online Access

Full Text (ProQuest Central) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

Send an e-mail